Sideraki V, Gilbert H F
Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030, USA.
Biochemistry. 2000 Feb 8;39(5):1180-8. doi: 10.1021/bi992246q.
Protein disulfide isomerase (PDI), a folding catalyst and chaperone can, under certain conditions, facilitate the misfolding and aggregation of its substrates. This behavior, termed antichaperone activity [Puig, A., and Gilbert, H. F., (1994) J. Biol. Chem. 269, 25889] may provide a common mechanism for aggregate formation in the cell, both as a normal consequence of cell function or as a consequence of disease. When diluted from the denaturant, reduced, denatured lysozyme (10-50 microM) remains soluble, although it does aggregate to form an ensemble of species with an average sedimentation coefficient of 23 +/- 5 S (approximately 600 +/- 100 kDa). When low concentrations of PDI (1-5 microM) are present, the majority (80 +/- 8%) of lysozyme molecules precipitate in large, insoluble aggregates, together with 87 +/- 12% of the PDI. PDI-facilitated aggregation occurs even when disulfide formation is precluded by the presence of dithiothreitol (10 mM). Maximal lysozyme-PDI precipitation occurs at a constant lysozyme/PDI ratio of 10:1 over a range of lysozyme concentrations (10-50 microM). Concomitant resolubilization of PDI and lysozyme from these aggregates by increasing concentrations of urea suggests that PDI is an integral component of the mixed aggregate. PDI induces lysozyme aggregation by noncovalently cross-linking 23 S lysozyme species to form aggregates that become so large (approximately 38,000 S) that they are cleared from the analytical ultracentrifuge even at low speed (1500 rpm). The rate of insoluble aggregate formation increases with increasing PDI concentration (although a threshold PDI concentration is observed). However, increasing lysozyme concentration slows the rate of aggregation, presumably by depleting PDI from solution. A simple mechanism is proposed that accounts for these unusual aggregation kinetics as well as the switch between antichaperone and chaperone behavior observed at higher concentrations of PDI.
蛋白质二硫键异构酶(PDI)作为一种折叠催化剂和伴侣蛋白,在某些条件下会促使其底物错误折叠并聚集。这种行为被称为抗伴侣活性[Puig, A., and Gilbert, H. F., (1994) J. Biol. Chem. 269, 25889],它可能为细胞内聚集体的形成提供一种常见机制,无论是作为细胞功能的正常结果还是疾病的后果。当从变性剂中稀释时,还原的、变性的溶菌酶(10 - 50 microM)仍可溶,尽管它确实会聚集形成一组平均沉降系数为23 ± 5 S(约600 ± 100 kDa)的物种。当存在低浓度的PDI(1 - 5 microM)时,大多数(80 ± 8%)的溶菌酶分子会与87 ± 12%的PDI一起沉淀形成大的不溶性聚集体。即使存在二硫苏糖醇(10 mM)阻止二硫键形成,PDI促进的聚集仍会发生。在一系列溶菌酶浓度(10 - 50 microM)范围内,当溶菌酶/PDI的恒定比例为10:1时,溶菌酶 - PDI沉淀达到最大值。通过增加尿素浓度使这些聚集体中的PDI和溶菌酶同时再溶解,这表明PDI是混合聚集体的一个组成部分。PDI通过将23 S溶菌酶物种非共价交联形成聚集体来诱导溶菌酶聚集,这些聚集体变得非常大(约38,000 S),以至于即使在低速(1500 rpm)下也能从分析超速离心机中沉降下来。不溶性聚集体的形成速率随PDI浓度的增加而增加(尽管观察到一个PDI浓度阈值)。然而,增加溶菌酶浓度会减缓聚集速率,推测是通过消耗溶液中的PDI来实现的。本文提出了一种简单的机制来解释这些不寻常的聚集动力学以及在较高浓度的PDI下观察到的抗伴侣和伴侣行为之间的转变。